Description
GLP-R is designed to activate three metabolic hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors. This triple-receptor research mechanism is being studied for its effects on metabolic regulation, glucose control, energy balance, and body weight.
GLP-R demonstrates significant weight reduction, while also showing potential benefits for several markers of metabolic health. Its effects on appetite-regulating pathways help reduce hunger and regulate food intake, supporting sustained weight-management efforts. By targeting three complementary metabolic signaling systems, GLP-R influences appetite, energy balance, glucose metabolism, and overall metabolic function.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption.
Reviews
There are no reviews yet.